SCOPUS 정보 검색 플랫폼

Volumn 9, Issue 11, 2000, Pages 2663-2671

Colesevelam hydrochloride: A non-absorbed, polymeric cholesterol-lowering agent

(4) Davidson, M H a Dicklin, M R a Maki, K C a Kleinpell, R M a

Author keywords

Bile acid sequestrants; Cardiovascular disease; Colesevelam hydrochloride; Coronary heart disease; HMG CoA reductase inhibitors; Hypercholesterolaemia; Lipid lowering therapy; Polymer

Indexed keywords

AMINE; ANTILIPEMIC AGENT; APOLIPOPROTEIN B; ATORVASTATIN; BILE ACID; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; EPICHLOROHYDRIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MEVINOLIN; PLACEBO; POLYMER; PRAVASTATIN; SIMVASTATIN; STATIN; TRIACYLGLYCEROL; TRIMETHYLAMMONIUM SALT DERIVATIVE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANIMAL EXPERIMENT; ARTICLE; ASTHENIA; BACKACHE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG APPROVAL; DRUG EFFECT; DRUG FORMULATION; DRUG MARKETING; DRUG POTENCY; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; INFECTION; INJURY; LIPID METABOLISM; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; MYOSITIS; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; RAT; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION;

EID: 0033758110 PISSN: 13543784 EISSN: None Source Type: Journal
DOI: 10.1517/13543784.9.11.2663 Document Type: Article

Times cited : (49)

References (31)

1
- 0030004051
- Cholesterol reduction: Weighing the benefits and risks
- (1996) Ann. Int. Med. , vol.124 , pp. 914-918
- Gaziano, J.M.¹ Bebert, P.R.² Hennekens, C.H.³

2
- 0000161902
- National Cholesterol Education Program Expert Panel: Second report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults.
- (1994) Circulation , vol.84 , pp. 1329-1445

3
- 0030888615
- Hypercholesterolemia in the United States: How far have we come?
- (1997) Am. J. Med. , vol.102 A , Issue.2 , pp. 3-6
- Brown, V.¹

4
- 0025183769
- Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipo-protein B
- (1990) N Engl. J. Med. , vol.323 , pp. 1289-1298
- Brown, G.¹ Albers, J.J.² Fisher, L.D.³

5
- 0007377385
- Cardiovascular risk reduction: What really works?
- (1997) Patient Care , pp. 47-60
- Castelli, W.P.¹ Ockene, J.K.² Roberts, W.C.³

6
- 0032572086
- Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
- (1998) JAMA , vol.279 , pp. 1615-1622
- Downs, J.¹ Clearfield, M.² Weis, S.³

7
- 0021350001
- Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention trial results I. Reduction in incidence of coronary heart disease.
- (1984) J. Am. Med. Assoc. , vol.251 , pp. 351-364

8
- 85037788536
- Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention trial results II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
- (1984) J. Am. Med. Assoc. , vol.151 , pp. 365-374

9
- 0342981862
- The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
- (1996) N. Engl. J. Med. , vol.335 , pp. 1001-1009
- Sacks, F.M.¹ Pfeffer, M.A.² Moye, L.A.³

10
- 0027987849
- Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S).
- (1994) Lancet , vol.344 , pp. 1383-1389

11
- 0028883828
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
- West of Scotland Coronary Prevention Study Group.
- (1995) N. Engl. J. Med. , vol.333 , pp. 1301-1307
- Shepherd, J.¹ Cobbe, S.M.² Ford, I.³

12
- 0032487931
- The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of cholesterol levels.
- (1998) N. Engl. J. Med. , vol.339 , pp. 1349-1357

13
- 0028967825
- Discontinuation of antihyperlipidemic drugs - Do rates reported in clinical trials reflect rates in primary care settings?
- (1995) N. Engl. J. Med. , vol.332 , pp. 1125-1131
- Andrade, S.E.¹ Walker, A.M.² Gottlieb, L.K.³

14
- 0032513736
- Persistence of use of lipid-lowering medications
- (1998) JAMA , vol.279 , pp. 1458-1462
- Avorn, J.¹ Monette, J.² Lacour, A.³

15
- 0032970790
- Challenges to best practice: Why are guidelines not implemented?
- (1999) Eur. Heart J. , vol.1 , Issue.SUPPL.
- Faergeman, O.¹

16
- 0031711503
- Aggressive lipid-lowering therapy: A clinical imperative
- (1998) Eur. Heart J.
- Pedersen, T.R.¹

17
- 0030892604
- American Heart Association Science Advisory Tast Force on Risk Reduction: Guide to primary prevention of cardiovascular diseases.
- (1997) Circulation , vol.95 , pp. 2329-2331

18
- 0033168558
- Despite good compliance, very low fat diet alone does not achieve recommended cholesterol goals in outpatients with coronary heart disease
- (1999) Eur. Heart J. , vol.20 , pp. 1020-1029
- Aquilani, R.¹ Tramarin, R.² Pedretti, R.F.³

19
- 0029828384
- Choosing the right lipid-regulating agent
- (1996) Drugs , vol.52 , pp. 649-661
- Farmer, J.A.¹ Gotto, A.M.²

20
- 0026557541
- HMG-CoA reductase inhibitors
- (1992) Curr. Opin. Lipidol. , vol.3 , pp. 22-28
- Hunninghake, D.¹

21
- 0001704782
- Dose-response study of colestipol tablets in patients with moderate hypercholesterolemia
- (1995) Am. J. Therap. , vol.2 , pp. 180-189
- Hunninghake, D.B.¹ Stein, E.A.² Bremner, F.³

22
- 0028332962
- Colestipol at varying dosage intervals in the treatment of moderate hypercholesterolaemia
- (1994) Br. J. Clin. Pharmacol. , vol.37 , pp. 59-62
- Lyons, D.¹ Webster, J.² Fowler, G.³ Petrie, J.C.⁴

23
- 0015092474
- Interruption of the enterohepatic circulation of bile acids in man: Comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism
- (1971) J. Lab. Clin. Med. , vol.178 , pp. 94-121
- Grundy, S.M.¹ Ahrens, E.H.² Salen, G.³

24
- 0030892604
- Guide to primary prevention of cardiovascular disease. A statement for healthcare professionals from the task force on risk reduction
- (1997) Circulation , vol.95 , pp. 2329-2331
- Grundy, S.M.¹ Balady, G.J.² Criqui, M.H.³

25
- 4243371928
- Dyslipidemia and atherosclerosis
- (1993) Circulation , vol.87 , Issue.SUPPL. 3
- Gotto, A.¹

26
- 0029156642
- Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia
- (1995) Am. Int. Med. , vol.123 , pp. 493-499
- Spence, D.¹ Huff, M.² Heidenheim, P.³

27
- 0033552130
- Colesevelam hydrochloride (cholestagel). A new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects
- (1999) Arch. Intern. Med. , vol.159 , pp. 1893-1900
- Davidson, M.H.¹ Dillon, M.A.² Gordon, B.³ Jones, P.⁴

28
- 0001709787
- Absorption of 14C-colesevelam hydrochloride in healthy male and female volunteers
- (1999) Pharm. Sci. , vol.1 , pp. 4085
- Heller, D.¹ Stevens, R.E.² Davidson, D.³ Donovan, J.⁴ Burke, S.⁵

29
- 0004505145
- Effect of cholestagel and lovastatin alone and in combination for the treatment of hypercholesterolemia
- (1998) XII International Symposium on DALM , pp. 60
- Mesner, C.H.¹ Burke, S.K.² Olson, T.³

30
- 4243217034
- Cholestagel, a novel, highly potent, polymeric bile acid sequestrant significantly lowers LDL cholesterol
- (2000) J. Am. Coll. Cardiol. , vol.35
- Insull, I.¹ Toth, P.² Mullican, W.³

31
- 0000631326
- Colesevelam HCI (WelChol), a new, potent, well tolerated, non-systemic lipid-lowering agent
- (2000) Atherosclerosis , vol.151 , pp. 130
- Davidson, M.¹ Hunninghake, D.² Olson, T.³ Donovan, J.⁴ Burke, S.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.